Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH for Steroid-Resistant/Dependent Nephrotic Syndrome in Children
NCT02972346Unknown
- Sponsor
- Xinhua Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of repository corticotropin injection in nephrotic syndrome, sponsored by Xinhua Hospital. Primary endpoint: 24-hour proteinuria excretion at 1.5 years. Status: unknown.
02
Drugs
repository corticotropin injection
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT02972346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972346.